Literature DB >> 22083896

Astragaloside IV and cycloastragenol stimulate the phosphorylation of extracellular signal-regulated protein kinase in multiple cell types.

Lisa Y Yung1, Wing See Lam, Maurice K C Ho, Yueqing Hu, Fanny C F Ip, Haihong Pang, Allison C Chin, Calvin B Harley, Nancy Y Ip, Yung H Wong.   

Abstract

Two Chinese herb-derived small molecule telomerase activators, astragaloside IV (AG-IV) and cycloastragenol (CAG), have recently been shown to improve the proliferative response of CD8+ T lymphocytes from HIV-infected patients by upregulating telomerase activity. Here, we examined the signaling mechanism of AG-IV and CAG. Telomerase activity in human embryonic kidney HEK293 fibroblasts was increased upon treatment with increasing concentrations of AG-IV or CAG. Both compounds induced the phosphorylation of extracellular signal-regulated protein kinase (ERK) in a time- and dose-dependent manner in HEK293 cells and HEK-neo keratinocytes. AG-IV and CAG also stimulated ERK phosphorylation in other cell lines of lung, brain, mammary, endothelial, and hematopoietic origins. Use of selective inhibitors and dominant negative mutants revealed the involvement of c-Src, MEK (ERK kinase), and epidermal growth factor receptor in CAG-induced ERK phosphorylation. Our data indicate that AG-IV and CAG may exert their cellular effects through the activation of the Src/MEK/ERK pathway. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22083896     DOI: 10.1055/s-0031-1280346

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  9 in total

Review 1.  Up-regulating telomerase and tumor suppressors: focusing on anti-aging interventions at the population level.

Authors:  Fernando Pires Hartwig; Daniel Bertoldi; Martin Larangeira; Mônica Silveira Wagner
Journal:  Aging Dis       Date:  2013-10-08       Impact factor: 6.745

Review 2.  Regulatory functions of Nm23-H2 in tumorigenesis: insights from biochemical to clinical perspectives.

Authors:  Yuanjun Li; Yao Tong; Yung H Wong
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-21       Impact factor: 3.000

Review 3.  Genome-Protecting Compounds as Potential Geroprotectors.

Authors:  Ekaterina Proshkina; Mikhail Shaposhnikov; Alexey Moskalev
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

4.  PIF1 Affects the Proliferation and Apoptosis of Cervical Cancer Cells by Influencing TERT.

Authors:  Jiancai Wang; Xiaoyan Zhu; Pian Ying; Yingping Zhu
Journal:  Cancer Manag Res       Date:  2020-08-25       Impact factor: 3.989

5.  Cadmium induced Drp1-dependent mitochondrial fragmentation by disturbing calcium homeostasis in its hepatotoxicity.

Authors:  S Xu; H Pi; Y Chen; N Zhang; P Guo; Y Lu; M He; J Xie; M Zhong; Y Zhang; Z Yu; Z Zhou
Journal:  Cell Death Dis       Date:  2013-03-14       Impact factor: 8.469

Review 6.  Anti-Aging Implications of Astragalus Membranaceus (Huangqi): A Well-Known Chinese Tonic.

Authors:  Ping Liu; Haiping Zhao; Yumin Luo
Journal:  Aging Dis       Date:  2017-12-01       Impact factor: 6.745

Review 7.  Articular Cartilage Aging-Potential Regenerative Capacities of Cell Manipulation and Stem Cell Therapy.

Authors:  Magdalena Krajewska-Włodarczyk; Agnieszka Owczarczyk-Saczonek; Waldemar Placek; Adam Osowski; Joanna Wojtkiewicz
Journal:  Int J Mol Sci       Date:  2018-02-22       Impact factor: 5.923

Review 8.  Cycloastragenol: An exciting novel candidate for age-associated diseases.

Authors:  Yongjie Yu; Limin Zhou; Yajun Yang; Yuyu Liu
Journal:  Exp Ther Med       Date:  2018-07-20       Impact factor: 2.447

9.  Development of an SPE-HPLC-MS method for simultaneous determination and pharmacokinetic study of bioactive constituents of Yu Ping Feng San in rat plasma after oral administration.

Authors:  Tao Li; Yiwei Wang; Yanli Wang; Rixin Liang; Dong Zhang; Huihui Zhang; Li Chen; Weipeng Yang
Journal:  J Ethnopharmacol       Date:  2012-12-20       Impact factor: 4.360

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.